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Introduction 
When considering the management of substance use in 
general practice, practitioners should focus on legal drugs, 
such as alcohol and prescription medication, as well as 
illegal drugs like heroin. The misuse of legal and illegal 
substances has a detrimental impact on global health.1,2 
Alcohol use alone is estimated to account for 3.8% of all 
global deaths and 4.8% of global disability-adjusted life 
years (defined as the years of life that are lost because of 
premature death and disability).2 
Substance use disorders are highly prevalent among South 
Africans. Estimates suggest that 13.3% of the population 
will suffer from a substance use disorder in their lifetime.3 
Alcohol is the most commonly abused substance in the 
country. South Africans are a nation of binge-drinkers. Up 
to a quarter of current drinkers engage in harmful alcohol 
use over weekends.4 Cannabis is the most common illegal 
drug that is abused.5 The exception is the Western Cape, 
where methamphetamine abuse is now more customary.6 
Behavioural addictions, such as pathological gambling, are 
also of concern, although they will not be discussed here. 
As a high percentage of South Africans suffer from 
a substance use disorder, general practitioners will 
increasingly play an important role in the assessment and 
management of patients with these conditions.
Diagnosing a substance use disorder
Substance use occurs on a continuum, ranging from use 
to abuse to dependence. It is important for practitioners to 
correctly identify the level of substance use, as this will have 
implications for its management. Many people are able to 
consume substances, such as alcohol, in a responsible 
manner that does not negatively interfere with their daily 
functioning. However, people may occasionally misuse 
substances, for example, driving while under the influence 
of alcohol. When the misuse of a substance becomes 
a regular pattern in a person’s life, he or she could be 
diagnosed with a substance use disorder.
Currently, the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR) distinguishes between substance 
abuse and dependence.7 A diagnosis of substance abuse 
requires that clinically significant impairment or distress has 
resulted from a maladaptive pattern of substance use. This 
may be characterised by any of the following occurring within 
a 12-month period: the failure to fulfil major obligations at 
work, school or home (e.g. absence from work); recurrent 
use of substances in physically hazardous situations (e.g. 
driving while under the influence); substance-related legal 
problems; and continued substance use despite recurrent 
social or interpersonal problems that relate to the use 
of substances (Criterion A). In addition, the individual 
should not meet the criteria for substance dependence 
(Criterion B)7. Substance dependence requires that the 
individual meet any three of the following criteria: tolerance; 
withdrawal; taking the substance in larger amounts or over 
a longer period than that intended; a persistent desire or 
unsuccessful efforts to control the substance use; spending 
considerable time in activities that relate to obtaining, 
using or recovering from the substance; giving up social, 
occupational or recreational activities because of substance 
use; and continuing with the substance use despite knowing 
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that use thereof has caused or exacerbated a physical or 
psychological problem.7 
The importance of screening and 
assessment
Despite high levels of substance use disorders, they are often 
missed in primary care settings. It is critical that screening 
for substance use forms part of routine assessment. The 
earlier the substance use problem is detected, the easier it 
is to manage and to provide effective treatment. 
Screening should include questions that relate to the 
frequency, quantity, method (e.g. smoking or injecting) and 
type of substances used. Patients may downplay their use. 
Therefore, it is important to clarify what is meant by “a bit”, 
“socially” or “just a few drinks”, for example. 
There are a number of screening tools that can assist 
with this process. The CAGE Questionnaire consists of 
four questions that are used to screen for an alcohol use 
problem.8 These are as follows:
•	 Have you ever felt you should cut down on your drinking? 
•	 Have people annoyed you by commenting on your 
drinking? 
•	 Have you ever felt bad or guilty about your drinking? 
•	 Have you ever had a drink first thing in the morning 
to steady your nerves or to dispel a hangover (an 
eye-opener)?
An affirmative response to two or more of the questions 
may indicate that the patient has an underlying alcohol 
use disorder and the practitioner should conduct a more 
comprehensive assessment of the patient’s alcohol use. 
The Alcohol Use Disorders Identification Test (AUDIT) is a 
10-item questionnaire that provides greater accuracy as 
to the degree of alcohol use,9 while the Alcohol, Smoking 
and Substance Involvement Screening Test (ASSIST) is a 
useful tool in evaluating the possible misuse of both legal 
and illegal substances.10 Both the AUDIT and the ASSIST 
can be downloaded free of charge from the World Health 
Organization’s website (www.who.int).
Co-morbidity
Patients with substance use disorders often present with 
co-occurring physical and psychiatric disorders. A myriad 
of physical complaints may provide an indication of an 
underlying substance use disorder. These may include 
gastrointestinal disorders, pancreatitis, liver disorders, 
hypertension, infectious diseases such as human 
immunodeficiency virus and Hepatitis B and C (resulting 
from unsafe sexual practices while under the influence of 
substances or from drug injection use), and skin infections 
caused by intravenous administration of substances.11 
Co-morbid psychiatric disorders are common in patients 
with substance use disorders. In particular, such patients 
may suffer from mood, anxiety,2 borderline and antisocial 
personality disorders.13 The risk of suicide attempts is also 
increased in patients with a dual diagnosis. The general 
practitioner should ask about ideation, plans or past 
attempts.14 Hospital admissions that relate to substance-
induced psychotic disorders are also becoming increasingly 
common in South Africa and often relate to the use of 
cannabis and methamphetamine.15 Local data suggest that 
at least 11.2% of South Africans with a mental disorder will 
suffer from a co-morbid psychiatric condition (including 
substance use disorders) in their lifetime.3 The co-morbidity 
of substance and psychiatric disorders is particularly high 
in hospitalised psychiatric patients. Fifty-one per cent 
of patients in a psychiatric hospital in the Western Cape 
province were diagnosed with a substance use disorder.15 
The interaction between psychiatric and substance use 
disorders is complex. Substance use may lead to a 
mental illness, such as a psychotic disorder; substances 
may be used to “self-medicate” for pre-existing mental 
health symptoms, for example to regulate mood in bipolar 
disorder; or both illnesses may occur independently in the 
same person. Pre-existing mental health symptoms may 
also worsen with the use of substances. Substance use and 
mental illness exacerbate each other. Substance use and 
psychiatric disorders can also mimic or mask the other’s 
symptoms.14,16 
It is important that dual diagnoses are identified, so that 
the patient can be treated for both disorders. Although 
traditionally it has been suggested that patients should 
undergo treatment for their substance problem prior to 
addressing other mental health problems, this is difficult 
to implement. Patients with co-morbid conditions are likely 
to struggle to remain abstinent for the required length of 
time. Therefore, integrated treatment is recommended. The 
patient should receive interventions for both the substance 
use and mental disorder in the same setting.12,14,16 
Management 
Brief interventions can be very effective in halting a person’s 
substance misuse, before it progresses to dependence.17 
Brief interventions can be conducted in as few as five to 
15 minutes. Objective, nonjudgemental feedback should 
be given to the patient on his or her substance use. 
Referring to the results of screening tools can be helpful. 
Following feedback, the practitioner should provide clear 
advice regarding the inherent risks in continued use of the 
substance. It is also useful to weigh up the advantages 
and disadvantages of using the substance with the patient 
so that discrepancies become apparent. The practitioner 
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who occasionally misuse alcohol, but who do not meet 
the criteria for a substance use disorder. Low-risk drinking 
includes no more than two standard drinks a day and at 
least two alcohol-free days a week.17 Total abstinence 
from alcohol and other drugs should be recommended 
to pregnant women. They should also be made aware of 
the resultant risks to the foetus when they drink or use 
drugs. The practitioner should engage with the patient in 
an empathic manner and provide the necessary support. 
Confrontational approaches to patients with substance 
use disorders are counter-productive. The patient is likely 
to withdraw from further communication with the treatment 
provider and may not return for treatment.18 
While brief interventions can be highly effective in patients 
with mild to moderate substance problems, they are not 
appropriate in patients who have been diagnosed with 
substance dependence.17 These patients require referral to 
specialist services, such as inpatient or intensive outpatient 
treatment. Where possible, the practitioner should involve 
family members who can provide social support to the 
patient and assist with the referral process. The practitioner 
may assume the role of case manager, exploring possible 
treatment options with the patient and linking him or her to a 
network of practitioners and organisations. The application 
of motivational interviewing may help to persuade patients 
who do not acknowledge that they have a problem with 
substance abuse to reach a stage in which they are ready to 
do so and accept assistance for their disorder. Motivational 
interviewing is an empathic, nonconfrontational client-
centred approach that aims to elicit positive behaviour 
change by resolving the patient’s ambivalence about 
his or her substance use. It is a technique that can be 
readily learned by general practitioners. By highlighting 
discrepancies between a patient’s present behaviour and 
his or her goal, it is hoped that he or she will become 
motivated to make changes. Rather than being authoritative, 
motivational interviewing allows the practitioner to evoke 
the client’s own intrinsic motivation for change.18 
Ideally, patients with dependence should be referred for 
treatment that includes group and individual therapy, skills 
training, cognitive-behavioural therapy, psychoeducational 
sessions, family involvement and relapse prevention. 
Patients who have a history of chronic alcohol dependence 
may require referral to a hospital or inpatient treatment 
centre for detoxification. Inpatient management is also 
recommended for patients who require detoxification from 
opioids.19 
Patients with opioid dependence, such as heroin, may 
benefit from opioid substitution therapy, which allows 
patients to regain functioning in their social life, work 
and relationships.20,21 Because of the potential for abuse, 
methadone use should always be supervised by another 
person. It requires intensive follow-up and repeat urine 
testing. Therefore, it should only be prescribed if supervision 
and structure are firmly in place and if a detailed physical 
and psychological assessment has transpired. As a partial 
mu-receptor agonist, buprenorphine (Subutex®) is a safer 
option, but should also be supervised initially.22 
Naltrexone (Revia®) is an opioid agonist that can be used 
to treat both alcohol and opioid dependence. It blocks the 
opioid receptors, lessening the effect of the drug and thereby 
reducing craving. However, naltrexone is not available in 
South Africa currently. Acamprosate (Besobrial®) is useful 
during the early period of abstinence from alcohol, as it 
reduces withdrawal symptoms and craving.22,23 
Practitioners should be cautious when prescribing 
benzodiazepines as, regardless of whether or not they 
have an underlying substance use disorder, patients on 
chronic benzodiazepine treatment may find it very difficult 
to withdraw. Although benzodiazepines may assist with 
the management of alcohol withdrawal symptoms, they 
should only be prescribed for short periods (no longer than 
two weeks) and patients should be informed about their 
addictive potential.19 
Substance dependence is a chronic disease. It features 
similar relapse rates to that of other chronic diseases 
such as hypertension and diabetes.24 Many patients will 
experience periods of relapse which should be viewed as 
learning opportunities. Follow-up is critical once patients 
have completed inpatient or intensive outpatient treatment. 
Patients may benefit from continued counselling or support 
groups, such as Alcoholics Anonymous or Narcotics 
Anonymous.
Conclusion
As a result of the high prevalence of substance use 
disorders, practitioners in general practice will increasingly 
be expected to screen for, assess and manage patients 
with substance use disorders. General practitioners may 
feel that it is not time-efficient to do so, but ultimately, early 
detection of substance use problems can save the general 
practitioner time and improve the patient’s prognosis.
Practitioners should be aware of the frequent psychiatric 
and physical co-morbidities that are associated with 
substance use. Although general practitioners may not 
feel comfortable treating substance use disorders, simple 
motivational interviewing techniques can quickly be learned, 
while co-morbid disorders may respond to standard medical 
treatment. Building up a strong network of colleagues 
and referral sources will assist with the comprehensive 
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No matter how bad it is, you can stop the 
nightmare”, says Alex Hamlin, a recovering 
drug addict who recounts his experience as an 
addict in Living with Drug Abuse, and explains 
how he managed to reclaim his life. Through 
Alex’s story, it becomes clear that drugs may not 
always be physically addictive, but they are always 
psychologically addictive. For more information 
on the “Living with” DVD-series visit the 
website, www.medihelplivingwith.co.za or phone 
0800 203 048 to order.
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